See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity

Summary by The Print
Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.

1 Articles

The PrintThe Print
Lean Right

Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.

·New Delhi, India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Print broke the news in New Delhi, India on Monday, August 11, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Ozempic icon

Ozempic

India icon

India

News
For You
SearchBlindspotLocal